kabutan

StemCell Institute, First Half Ordinary Profit Decreases by 48%, Jul-Sep Ordinary Profit Decreases by 51%

Wed Nov 12, 2025 3:30 pm JST Earnings

7096 StemCell Institute 【J-GAAP】

Earnings Report

StemCell Institute <7096> [TSE Growth] announced its financial results after the market closed on November 12th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2026 (April to September) dropped 48.5% from the previous period non-consolidated to 136 million yen. Progress toward the full-year plan of 450 million yen was 30.2%, also falling below the five-year average of 53.9%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to expand 91.5% from the previous period non-consolidated to 314 million yen.

In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit significantly dropped to 69 million yen, a 50.7% decrease compared to the same period last year. The operating profit margin sharply declined from 19.4% in the same period last year to 9.1%.

Note: Since the current fiscal year, the company has transitioned to consolidated financial statements.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2023 1,213 215 216 159 15.6 51.8 Nov 8, 2023 J-GAAP
Apr - Sep, 2024 1,373 258 264 271 26.5 61.7 Nov 12, 2024 J-GAAP
Apr - Sep, 2025 1,415 130 136 84 8.4 30.2 Nov 12, 2025 J-GAAP
YoY +3.1% -49.6% -48.5% -69.0% -68.4%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 Guidance ー ー ー ー － 0 May 13, 2025 J-GAAP
Apr - Sep, 2025 Results 1,415 130 136 84 8.4 0 Nov 12, 2025 J-GAAP
Revision Rate － － － － －

Guidance Update

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Prev 3,000 450 450 320 31.8 0 May 13, 2025 J-GAAP
Mar, 2026 New 3,000 450 450 320 31.8 0 Nov 12, 2025 J-GAAP
Revision Rate 0.0% 0.0% 0.0% 0.0% 0.0%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 1,306 160 164 114 11.2 0 May 13, 2025 J-GAAP
Oct - Mar, 2025 Guidance 1,585 320 314 236 23.4 0 Nov 12, 2025 J-GAAP
YoY +21.4% +100.0% +91.5% +107.0% +110.2%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 2,481 413 417 310 30.4 0 May 14, 2024 J-GAAP
Mar, 2025 2,679 418 428 385 37.7 25 May 13, 2025 J-GAAP
Mar, 2026 Guidance 3,000 450 450 320 31.8 0 Nov 12, 2025 J-GAAP
YoY +12.0% +7.7% +5.1% -16.9% -15.6%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 695 135 140 93 9.1 19.4 Nov 12, 2024 J-GAAP
Oct - Dec, 2024 667 100 103 68 6.7 15.0 Feb 13, 2025 J-GAAP
Jan - Mar, 2025 639 60 61 46 4.5 9.4 May 13, 2025 J-GAAP
Apr - Jun, 2025 700 65 67 43 4.2 9.3 Aug 7, 2025 J-GAAP
Jul - Sep, 2025 715 65 69 41 4.1 9.1 Nov 12, 2025 J-GAAP
YoY +2.9% -51.9% -50.7% -55.9% -55.1%

Related Articles